Myelodysplastic syndromes should been renamed as myelodysplastic neoplasms.
|
Jan 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Improving the prognostic assessment of myelodysplastic syndromes by understanding the biology of the disease
|
Jul 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes
|
Feb 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Molecular genetics in myelodysplastic syndromes
|
Sep 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Good riddance to the term "refractory anemia" in myelodysplastic syndromes
|
Oct 2016
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases
|
Mar 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis
|
Feb 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
New therapeutics for myelodysplastic syndromes
|
Sep 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative
|
Jan 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Variations in erythropoiesis-stimulating agent administration in transfusion-dependent myelodysplastic syndromes impact response
|
Mar 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|